本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

MAIA Biotechnology Inc.

1.96
+0.01000.51%
盘后1.980.0200+1.02%19:31 EDT
成交量:10.15万
成交额:20.08万
市值:5,799.11万
市盈率:-1.87
高:2.04
开:1.98
低:1.90
收:1.95
数据加载中...
2023/04/20

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/04/20

重要事件披露

8-K - Current report
2023/04/18

SEC问询函

Form CORRESP - Correspondence
2023/04/18

SEC问询函

Form CORRESP - Correspondence
2023/04/18

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/04/18

重要事件披露

8-K - Current report
2023/04/11

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/04/11

重要事件披露

8-K - Current report
2023/04/07

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/04/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/24

重要事件披露

8-K - Current report
2023/03/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/17

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

重要事件披露

8-K/A [Amend] - Current report
2023/02/13

重要事件披露

8-K - Current report
2023/02/13

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/06

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933